Neuregulin: An Oligodendrocyte Growth Factor Absent in Active Multiple Sclerosis Lesions

Publisher： Karger

E-ISSN： 1421-9859|23|4-5|377-386

ISSN： 0378-5866

Source： Developmental Neuroscience, Vol.23, Iss.4-5, 2001-12, pp. : 377-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GRO-α and CXCR2 in the Human Fetal Brain and Multiple Sclerosis Lesions

By  

Developmental Neuroscience, Vol. 25, Iss. 2-4, 2003-09 ,pp. : 279-290

Karger

Access to resources Recommend Favorite

Uveitis and the Diagnosis of Multiple Sclerosis

By  

Canadian Journal of Neurological Sciences, Vol. 44, Iss. 3, 2016-06 ,pp. : 334-335

Cambridge University Press

Access to resources Recommend Favorite

Fibroblast Growth Factors and Their Receptors in Oligodendrocyte Development: Implications for Demyelination and Remyelination

By  

Developmental Neuroscience, Vol. 24, Iss. 1, 2002-07 ,pp. : 35-46

Karger

Access to resources Recommend Favorite

Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update – ERRATUM

By  

Canadian Journal of Neurological Sciences, Vol. 44, Iss. 4, 2016-01 ,pp. : 467-467

Cambridge University Press

Access to resources Recommend Favorite

Growth Factor Control of CNS Myelination

By  

Developmental Neuroscience, Vol. 23, Iss. 4-5, 2001-12 ,pp. : 327-337

Karger

Access to resources Recommend Favorite